Kalvista Pharmaceuticals Inc (KALV) Insider Trading
- $45,015,517.47
- $69,649,984.03
- Sept. 9, 2024
- Thomas Andrew Crockett
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 9, 2024 | CEO | 7,352 | $12.19 | Sell | $89,620.88 | |
Aug. 23, 2024 | Insider | 2,135 | $12.40 | Sell | $26,474.00 | |
Aug. 19, 2024 | CEO | 14,215 | $12.01 | Sell | $170,722.15 | |
Aug. 19, 2024 | Insider | 7,102 | $12.01 | Sell | $85,295.02 | |
June 7, 2024 | CEO | 7,465 | $11.53 | Sell | $86,071.45 | |
May 20, 2024 | CEO | 21,959 | $11.76 | Sell | $258,237.84 | |
May 20, 2024 | Insider | 8,088 | $11.76 | Sell | $95,114.88 | |
Feb. 20, 2024 | CFO | 22,802 | $14.11 | Sell | $321,736.22 | |
Feb. 20, 2024 | Insider | 28,288 | $14.07 | Sell | $398,012.16 | |
Feb. 20, 2024 | CEO | 24,888 | $14.11 | Sell | $351,169.68 | |
Feb. 8, 2024 | Major Shareholder | 29,747 | $14.70 | Buy | $437,280.90 | |
Feb. 6, 2024 | Major Shareholder | 4,474 | $14.74 | Buy | $65,946.76 | |
Jan. 29, 2024 | Major Shareholder | 80,600 | $14.22 | Buy | $1,146,132.00 | |
Jan. 26, 2024 | Major Shareholder | 4,174 | $12.98 | Buy | $54,178.52 | |
Jan. 24, 2024 | Major Shareholder | 20,686 | $12.44 | Buy | $257,333.84 | |
Jan. 22, 2024 | Major Shareholder | 67,546 | $12.55 | Buy | $847,702.30 | |
Jan. 18, 2024 | Major Shareholder | 39,680 | $12.51 | Buy | $496,396.80 | |
Jan. 16, 2024 | Major Shareholder | 19,599 | $12.73 | Buy | $249,495.27 | |
Jan. 11, 2024 | Insider | 22,679 | $13.03 | Sell | $295,507.37 | |
Jan. 10, 2024 | Major Shareholder | 47,700 | $12.67 | Buy | $604,359.00 | |
Jan. 8, 2024 | Major Shareholder | 69,184 | $12.44 | Buy | $860,648.96 | |
Jan. 8, 2024 | Insider | 17,221 | $13.01 | Sell | $224,045.21 | |
Jan. 3, 2024 | Major Shareholder | 17,605 | $12.20 | Buy | $214,781.00 | |
Dec. 29, 2023 | Major Shareholder | 6,013 | $12.49 | Buy | $75,102.37 | |
Dec. 27, 2023 | CEO | 30,000 | $12.02 | Sell | $360,600.00 | |
Dec. 27, 2023 | Major Shareholder | 41,514 | $11.97 | Buy | $496,922.58 | |
Sept. 11, 2023 | Director | 18,000 | $10.50 | Sell | $189,000.00 | |
Aug. 18, 2023 | CEO | 14,876 | $10.73 | Sell | $159,619.48 | |
Aug. 18, 2023 | Insider | 8,020 | $10.73 | Sell | $86,054.60 | |
Aug. 18, 2023 | CFO | 13,067 | $10.73 | Sell | $140,208.91 | |
May 18, 2023 | CEO | 5,627 | $10.14 | Sell | $57,057.78 | |
May 18, 2023 | CFO | 4,037 | $10.14 | Sell | $40,935.18 | |
May 18, 2023 | Insider | 2,604 | $10.14 | Sell | $26,404.56 | |
Feb. 17, 2023 | CEO | 6,700 | $7.66 | Sell | $51,322.00 | |
Feb. 17, 2023 | Insider | 3,412 | $7.66 | Sell | $26,135.92 | |
Feb. 17, 2023 | CFO | 4,954 | $7.66 | Sell | $37,947.64 | |
Nov. 18, 2022 | Insider | 1,139 | $5.44 | Sell | $6,196.16 | |
Nov. 18, 2022 | CFO | 722 | $5.44 | Sell | $3,927.68 | |
Nov. 18, 2022 | CEO | 1,785 | $5.44 | Sell | $9,710.40 | |
Aug. 17, 2022 | CEO | 1,797 | $14.96 | Sell | $26,883.12 | |
March 9, 2022 | CEO | 10,000 | $17.07 | Sell | $170,700.00 | |
Nov. 1, 2021 | Insider | 6,000 | $18.07 | Sell | $108,420.00 | |
Oct. 1, 2021 | CEO | 10,000 | $17.18 | Sell | $171,800.00 | |
Aug. 2, 2021 | Insider | 5,000 | $20.52 | Sell | $102,600.00 | |
July 1, 2021 | CEO | 10,000 | $24.15 | Sell | $241,500.00 | |
June 17, 2021 | CEO | 1,067 | $30.04 | Sell | $32,052.68 | |
June 9, 2021 | CEO | 8,933 | $30.05 | Sell | $268,436.65 | |
May 3, 2021 | Insider | 5,000 | $24.84 | Sell | $124,200.00 | |
April 29, 2021 | SVP | 88,030 | $25.28 | Sell | $2,225,398.40 | |
April 28, 2021 | VP | 10,014 | $25.76 | Sell | $257,960.64 |
Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.
The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Christopher Yea, Venrock Healthcare Capital Par, Benjamin L Palleiko, Edward P Feener, Albert Cha, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Paul K Audhya, Andreas Maetzel, Acmp Iv Llc, David Renzi, Daniel B Soland, Rajeev M Shah, and Michael David Smith
The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.
Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.
Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.
The most recent insider trade for Kalvista Pharmaceuticals Inc was on Sept. 9, 2024.
The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.
The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.